87
Participants
Start Date
May 31, 2014
Primary Completion Date
November 30, 2014
Study Completion Date
October 31, 2015
Liraglutide
the dosage of liraglutide was 0.6 mg/day during the first week, 1.2 mg/day during the second week, and 1.8 mg/day from the third week to the conclusion of the study
Metformin
the dosage of metformin was 250 mg thrice a day during the first week, 500 mg thrice a day during the second week, and 1000 mg twice a day from the third week to the conclusion of the study
Gliclazide
the initial dosage of gliclazide was 30 mg before breakfast, which was gradually titrated to a maximum of 120 mg/day to achieve a fasting capillary plasma glucose of \<7.0 mmol/L
at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University, Nanjing
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
OTHER